SOBR Safe Inc. has reported its financial and operating results for the first quarter ended March 31, 2025. The company experienced a significant 80.5% increase in total revenue, reaching $86.6 thousand compared to $48.0 thousand in the same period of 2024. The net loss improved to $1.9 million from $2.5 million in the first quarter of 2024. The company's gross margin rose to 58.8%, up from 48.4% in the previous year. Operating expenses increased to $2.0 million from $1.7 million due to higher general and administrative costs related to a growing employee headcount, partly offset by reduced third-party professional service fees. SOBR Safe Inc. deployed 148 SOBRsureTM devices in the first quarter, marking a 41.0% increase compared to December 31, 2024. The company also enhanced its patent-pending software technology with updates to its mobile application, which included improved administrative tools, upgraded notification protocols, and a redesigned user interface. Additionally, the company added Dr. Benjamin Sanchez as a Scientific Advisor to explore non-dilutive federal funding, licensing opportunities, and clinical research partnerships. Cash and cash equivalents stood at $10.1 million at the end of the first quarter, up from $8.4 million at the end of 2024, bolstered by approximately $3.3 million in net proceeds from the exercise of outstanding warrants.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。